2019
DOI: 10.1016/j.oraloncology.2019.04.019
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
108
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 128 publications
(120 citation statements)
references
References 41 publications
11
108
0
1
Order By: Relevance
“…At the same time, the prognostic significance of CD68 + infiltration in relation to other clinical endpoints could not be demonstrated. This finding is in line with the conclusions of the meta-analysis presented by Troiano et al [30], taking into account the results of 17 studies conducted on 1,528 patients with oral cancer, which excluded the prognostic significance of CD68 + infiltrates in this group of cancers and confirmed the usefulness of M2-like macrophage infiltrates assessment in the tumour stroma as an adverse prognostic factor. The results presented by us also indicate the usefulness of the CD163 + infiltration assessment in the tumour stroma as a negative prognostic factor in regard to the LRC, distant metastases-free survival and OS in the group of HPV-negative patients.…”
Section: Discussion/conclusionsupporting
confidence: 91%
See 1 more Smart Citation
“…At the same time, the prognostic significance of CD68 + infiltration in relation to other clinical endpoints could not be demonstrated. This finding is in line with the conclusions of the meta-analysis presented by Troiano et al [30], taking into account the results of 17 studies conducted on 1,528 patients with oral cancer, which excluded the prognostic significance of CD68 + infiltrates in this group of cancers and confirmed the usefulness of M2-like macrophage infiltrates assessment in the tumour stroma as an adverse prognostic factor. The results presented by us also indicate the usefulness of the CD163 + infiltration assessment in the tumour stroma as a negative prognostic factor in regard to the LRC, distant metastases-free survival and OS in the group of HPV-negative patients.…”
Section: Discussion/conclusionsupporting
confidence: 91%
“…As we know this is the first publication covering such a homogeneous group of patients with a comparable number of HPV-positive and HPV-negative cases and one of the few in which the HPV double-detection algorithm was used. Most of the publications in which the intensity of macrophage infiltration within head and neck tumours was analysed concerned locations in the oral cavity [30] or other locations outside the oropharynx [31], where HR-HPV status was unknown. Due to the low frequency of HR-HPV infections in the 2.5-4% range in these anatomical sites, it can be assumed that the results presented in them relate mainly to the HPV-negative population [32][33][34].…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…Head and neck squamous cell carcinoma (HNSCC) is a member of highly aggressive tumors that involve the epithelium numerous anatomical sections, such as the oral cavity [151]. Zhang et al demonstrated that miR-144-3p, by targeting of ETS-1 and insulin receptor substrate 1 (IRS1) in laryngeal squamous cell carcinoma, led to the inhibition of metastasis and invasion of tumor cells.…”
Section: Mir-144 In Head and Neck Squamous Cell Carcinomamentioning
confidence: 99%
“…Immunostains were done on paraffin-embedded sections using the Ventana Discovery DAB Map System (Ventana, Illkirch, France), as previously described [9]. We assessed macrophages using CD68 (anti-CD68, DAKO IR613, dilution 1:2), CD163 for M2-like macrophages (anti-CD163, Abcam Ab74604, neat) and HLA-DR for M1-like macrophages (anti-HLA-DR, Abcam Ab20181 [TAL1B5], dilution 1:100) [14,[33][34][35], lymphocytes using CD8 for cytotoxic T cells (anti-CD8, DAKO M7103, dilution 1:100), CD4 for T helper cells (anti-CD4, Abcam Ab133616, dilution 1:100), FOXP3 for T regulatory cells (anti-FOXP3, Abcam Ab20034 [236 A/E7], dilution 1:50), CD20 for B lymphocytes (anti-CD20, DAKO M0755, dilution 1:300) and neutrophil elastase for neutrophils (anti-neutrophil elastase, Abcam Ab68672, dilution 1:100). To study endothelial cells we used the marker CD31 (anti-CD31, DAKO M0823, dilution 1:100), and we also took into consideration their location and morphology.…”
Section: Immunohistochemical Analysismentioning
confidence: 99%